We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
73 hedge funds and large institutions have $213M invested in scPharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,525% more call options, than puts
Call options by funds: $1.3M | Put options by funds: $36K
3.69% more ownership
Funds ownership: 79.78% → 83.47% (+3.7%)
10% less funds holding
Funds holding: 81 → 73 (-8)
19% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 27
27% less capital invested
Capital invested by funds: $291M → $213M (-$77.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Holders
73
Holders Change
-8
Holders Change %
-9.88%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
7
Increased
22
Reduced
27
Closed
14
Calls
$1.3M
Puts
$36K
Net Calls
+$1.27M
Net Calls Change
+$717K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.92M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$2.71M |
| 3 |
Walleye Capital
New York
|
-$1.05M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.03M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$673K |
